Effect of process variables on morphology and aerodynamic properties of voriconazole formulations produced by thin film freezing

International Journal of Pharmaceutics

Volumn 429, Issue 1-2, 2012, Pages 46-57

  Beinborn, Nicole A ^a   Lirola, Hélène L ^a   Williams III, Robert O ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Amorphous; Crystalline; Dry powder inhalation; Poorly water soluble drug; Ultra rapid freezing, nanotechnology

Indexed keywords

DIOXANE; EXCIPIENT; POLYMER; POVIDONE DERIVATIVE; SOLVENT; VORICONAZOLE;

AIRWAY DYNAMICS; ARTICLE; BIOFILM; DRUG FORMULATION; FREEZING; MORPHOLOGY; PHARMACEUTICAL ENGINEERING; POWDER INHALER; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SOLID STATE; THIN FILM FREEZING;

ADMINISTRATION, INHALATION; ANTIFUNGAL AGENTS; CRYSTALLIZATION; DIOXANES; DRY POWDER INHALERS; EXCIPIENTS; FREEZING; NANOSTRUCTURES; PARTICLE SIZE; POLYMERS; POVIDONE; POWDERS; PYRIMIDINES; SOLVENTS; TECHNOLOGY, PHARMACEUTICAL; TRIAZOLES;

EID: 84862832377     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.03.010     Document Type: Article

References (38)

1. F.J. Bhavna Ahmad, G. Mittal, G.K. Jain, G. Malhotra, R.K. Khar, and A. Bhatnagar Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions Eur. J. Pharm. Biopharm. 71 2009 282 291
2. C.M. Buchanan, N.L. Buchanan, K.J. Edgar, and M.G. Ramsey Solubilty and dissolution studies of antifungal drug:hydroxybutenyl-β-cyclodextrin complexes Cellulose 14 2007 35 47 (Pubitemid 46486879)
3. A.H. Chow, H.H. Tong, P. Chattopadhyay, and B.Y. Shekunov Particle engineering for pulmonary drug delivery Pharm. Res. 24 2007 411 437 (Pubitemid 46295160)
4. J.C. Dinunzio, C. Brough, J.R. Hughey, D.A. Miller, R.O. Williams 3rd., and J.W. McGinity Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and kinetisol dispersing Eur. J. Pharm. Biopharm. 74 2010 340 351
5. S.R. Doffman, S.G. Agrawal, and J.S. Brown Invasive pulmonary aspergillosis Expert Rev. Anti Infect. Ther. 3 2005 613 627 (Pubitemid 41223221)
6. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. BenJebria, M.L. Eskew, J. Mintzes, D. Deaver, N. Lotan, and R. Langer Large porous particles for pulmonary drug delivery Science 276 1997 1868 1871 (Pubitemid 27443665)
7. FDA Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System 2000
8. FisherScientific Material Safety Data Sheet: 1,4-Dioxane 2009
9. A. Forster, J. Hempenstall, I. Tucker, and T. Rades Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis Int. J. Pharm. 226 2001 147 161 (Pubitemid 32800790)
10. P. Gabbott, P. Clarke, T. Mann, P. Royall, and S. Shergill A high-sensitivity, high-speed DSC technique: measurement of amorphous lactose Am. Lab. 17 2003
11. M. Gordon, and J.S. Taylor Ideal copolymers and the second order transitions of synthetic rubbers. I. Non crystalline copolymers J. Appl. Chem. 2 1952 493 500
12. B.C. Hancock, and G. Zografi The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids Pharm. Res. 11 1994 471 477 (Pubitemid 24144434)
13. B.C. Hancock, and G. Zografi Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 86 1997 1 12
14. R. Herbrecht Voriconazole: therapeutic review of a new azole antifungal Expert Rev. Anti Infect. Ther. 2 2004 485 497 (Pubitemid 39162360)
15. J. Huang, and R.J. Wigent Determination of drug and polymer miscibility and solid solubility for design of stable amorphous solid dispersions Am. Pharm. Rev. July/August 2009 18 20,22,24-26
16. Johnston, K.P., Engstrom, J., Tam, J., Watts, A., 2010. Compositions and Methods of Making Brittle-matrix Particles through Blister Pack Freezing. United States Patent & Trademark Office, US 2010/0221343.
17. C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60 (Pubitemid 30326688)
18. C.A. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235 249 (Pubitemid 32239479)
19. T. Mao, D.C.S. Kuhn, and H. Tran Spread and Rebound of Liquid Droplets upon Impact on Flat Surfaces AIChE J. 43 1997 2169 2179
20. P.J. Marsac, T. Li, and L.S. Taylor Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters Pharm. Res. 26 2009 139 151
21. R.M. Mazo Brownian Motion: Fluctuations, Dynamics, and Applications 2002 Oxford University Press New York
22. J.P. Mitchell Practices of Coating Collection Surfaces of Cascade Impactors: A Survey of Members of the European Pharmaceutical Aerosol Group (EPAG), Drug Delivery to the Lungs-14 2003 The Aerosol Society London, UK pp. 75-78
23. K.A. Overhoff, J.D. Engstrom, B. Chen, B.D. Scherzer, T.E. Milner, K.P. Johnston, and R.O. Williams 3rd. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs Eur. J. Pharm. Biopharm. 65 2007 57 67 (Pubitemid 44827696)
24. K.A. Overhoff, K.P. Johnston, J. Tam, J.D. Engstrom, and R.O. Williams 3rd. Use of thin film freezing to enable drug delivery: a review J. Drug Deliv. Sci. Technol. 19 2009 89 98
25. A. Pascual, V. Nieth, T. Calandra, J. Bille, S. Bolay, L.A. Decosterd, T. Buclin, P.A. Majcherczyk, D. Sanglard, and O. Marchetti Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods Antimicrob. Agents Chemother. 51 2007 137 143 (Pubitemid 46047698)
26. Pfizer, 2011. VFEND® Prescribing Information [cited August 7, 2011]. Available from: http://www.pfizer.com/files/products/uspi-vfend.pdf.
27. S.J. Roffey, S. Cole, P. Comby, D. Gibson, S.G. Jezequel, A.N.R. Nedderman, D.A. Smith, D.K. Walker, and N. Wood The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human Drug Metab. Dispos. 31 2003 731 741 (Pubitemid 36617661)
28. R. Simha, and R. Boyer On a general relation involving the glass temperature and coefficients of expansion of polymers J. Chem. Phys. 37 1962 1003
29. B. Sinha, and B. Mukherjee Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model Drug Dev. Ind. Pharm. 38 2012 171 179
30. Sundaram, V., Uppala, V.B.R., Akundi, S.P., Muvva, V., Chitta, V., Donthula, A., Kharkar, M.R., Devarakonda, S.N., Peddireddy, S.R., 2008. Process for Preparing Voriconazole. United States Patent & Trademark Office, US 2008/0194820.
31. M.J. Telko, and A.J. Hickey Dry powder inhaler formulation Respir. Care 50 2005 1209 1227 (Pubitemid 46187575)
32. United States Pharmacopeia (USP) General Chapter 601: Aerosols, Nasal Sprays, Metered-dose Inhalers, and Dry Powder Inhalers 2010 USP 32-NF 27 Rockville, MD, USA
33. United States Pharmacopeia (USP) General Chapter 647: Residual Solvents 2010 USP 32-NF 27 Rockville, MD, USA
34. C. Wohlfarth Surface Tension of Pure Liquids and Binary Liquid Mixtures (Supplement to IV/16) 2008 Springer Berlin
35. Y. Xie, P. Zeng, and T.S. Wiedmann Disease guided optimization of the respiratory delivery of microparticulate formulations Expert Opin. Drug Deliv. 5 2008 269 289 (Pubitemid 351454378)
36. W. Yang, J.I. Peters, and R.O. Williams Inhaled nanoparticles - a current review Int. J. Pharm. 356 2008 239 247
37. W. Yang, J. Tam, D.A. Miller, J. Zhou, J.T. McConville, K.P. Johnston, and R.O. Williams High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers Int. J. Pharm. 361 2008 177 188
38. J. Zhang, L. Wu, H.K. Chan, and W. Watanabe Formation, characterization, and fate of inhaled drug nanoparticles Adv. Drug Deliv. Rev. 63 2011 441 455